.

Contrast Media

Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimitedis mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Contrast Media domestic. It has around 650 employees with 0.82 Bn/¥ revenue in 2019. Beilu provides complete Contrast Media products Include ct contrast medium, mri contrast medium, gadopentetate dimeglumine,etc, and it is the leading manufacturer in the Contrast Media field in China. It is one of the 1st batches of listed enterprises in GEM of SZSE (Ticker: 300016.SZ) in China.

For the purpose of medical imaging agents, a certain substance is introduced into the human body to change the image contrast of local tissues of the body. This introduced substance is Contrast Media, also known as iv Contrast Agents. As the first contrast media companies in China, Beilu Pharma launched the domestic MRI Contrast Media Gadopentetate Dimeglumine Injection in 1992, which broke the foreign products monopoly and filled the domestic gap. As a professional contrast media manufacturing companies, we could provide a broad portfolio stems Contrast Media across CT/X-ray and MRI modalities, and own the EU standard manufacturing facilities.

Types of Contrast Media in Beilu Pharma
MRI CONTRAST MEDIA
Magnetic Resonance Imaging (MRI)Contrast Media is Gadolinium based contrast agent(GBCA). It is an intravenous injection, mainly used to enhance the image quality of internal organs, blood vessels and tissues during MRI examinations. GBCA contains gadolinium, which is connected to each other through carrier molecules to form a chelating agent. According to the different chemical structures, this contrast medium can be divided into two categories: linear and macrocyclic. The linear structure of the imaging agents is easier to release gadolinium ions, and the macrocyclic structure of the contrast material is more stable and less likely to release gadolinium ions.

Finished product list

S. No Product name Characteristic Specification
1 Gadopentetate Dimeglumine Injection Injectable solution 469mg/ml: 10ml, 12ml, 15ml, 20ml
2 Gadobutrol Injection Injectable solution 604.72mg/ml: 7.5ml
3 Ferric Ammonium Citrate Effervescent Granules Oral granules 3g:0.6g(Fe 129mg)
6g:1.2g(Fe 258mg)
4 Iopamidol Injection Injectable solution 300mgI/ml: 50ml, 100ml
370mgI/ml: 50ml, 100ml
5 Iodixanol Injection Injectable solution 270mgI/ml: 100ml
320mgI/ml: 50ml, 100ml
6 Iohexol Injection Injectable solution 300mgI/ml: 20ml,50ml,75ml, 100ml
350mgI/ml: 20ml, 50ml, 100ml
API & Intermediates Product list
S. No Products CAS NO. Packings Classification
1 Iohexol 66108-95-0 25kg Contrast agent
2 Iodixanol 92339-11-2 25kg Contrast agent
3 Iopromide 73334-07-3 25kg Contrast agent
4 Iopamidol 60166-93-0 25kg Contrast agent
5 Ioversol 87771-40-2 25kg Contrast agent
6 Gadopentetate Monomeglumine 92923-57-4 25kg Contrast agent
7 Gadopentetate Dimeglumine 86050-77-3 25kg Contrast agent
8 Gadobutrol 25kg Contrast agent
9 Calcobutrol 2kg Excipients
10 Repaglinide 10kg Anti-diabetic
11 Diethylenetriaminepentaacetic acid ( Pentaacetic Acid)(DTPA) 67-43-6 2.5kg Intermediates
12 IOPAMIDOL INTERMEDIATE
(order based) 5-Amino-2,4,6-triiodoisophthalic acid 35453-19-1 25kg Intermediates

We will provide intravascular contrast media, ct cisternography contrast, iv contrast medication contraindications and so on.



在线联系供应商

至: 北京北陆药业股份有限公司
Your E-mail:
消息正文:


Send to other suppliers

Other supplier products

Anti-Diabetic Drugs
Anti-Diabetic Drugs The number of people with diabetes rose from 151 million in 2000 to 463 million in 2019; by 2045 this number will rise to 700 million. 1 in 5 of th...
Ferric Ammonium Citrate Effervescent Granules
Ferric Ammonium Citrate Effervescent Granules Ferric AmmoniumCitrate Effervescent Granules was launched in 2004. It is an oral magnetic resonance contrast agent/media approved by NMPA in the ma...
Gadopentetate Dimeglumine Injection/API
Gadopentetate Dimeglumine Injection/API Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimitedis mainly engaged in the research & development, production and sales of pharmaceutic...
Anti-Anxiety Drug
Anti-Anxiety Drug Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimitedis mainly engaged in the research & development, production and sales of pharmaceutic...
CT/X-Ray Contrast Media
CT/X-Ray Contrast Media Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimited is mainly engaged in the research & development, production and sales of pharmaceuti...
供应产品

Same products

Iodixanol Injection
Iodixanol Injection 卖方: 北京北陆药业股份有限公司 IodixanolInjection is a Contrast Media that is isotonic with plasma. It has excellent cardiac saf...
Glimepiride Tablets
Glimepiride Tablets 卖方: 北京北陆药业股份有限公司 Glimepiride Tablets is a sulfonylurea hypoglycemic drug that can be used in combination with insu...
Gadopentetate Dimeglumine Injection/API
Gadopentetate Dimeglumine Injection/API 卖方: 北京北陆药业股份有限公司 Since Gadopentetate Dimeglumine Injection was launched in 1992 by Beilu Pharma in China, it was h...
Gadobutrol Injection/API
Gadobutrol Injection/API 卖方: 北京北陆药业股份有限公司 In 2020, Beilu launched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-ba...
Ferric Ammonium Citrate Effervescent Granules
Ferric Ammonium Citrate Effervescent Granules 卖方: 北京北陆药业股份有限公司 Ferric AmmoniumCitrate Effervescent Granules was launched in 2004. It is an oral magnetic resonan...